drugset / Trial / NCT04251351
Effect of Paracetamol on Kidney Function in Severe Malaria
Phase 3
Unknown
460 enrolled
University of British Columbia
Kinshasa Medical Oxford Research Unit · collabMahidol Oxford Tropical Medicine Research Unit · collab
RandomizedParallel-groupOpen-labelPrevention
Summary
A randomised open labeled, parallel-group, controlled trial to assess the efficacy of paracetamol to reduce kidney dysfunction caused by cell-free haemoglobin-mediated oxidative damage in paediatric patients with falciparum malaria complicated by intravascular haemolysis.
Timeline
- Start
- 2021-12-13
- Primary completion
- 2024-06-01
- Completion
- 2025-11-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Acetaminophen | Small molecule | 15 mg/kg | Intravenous |